查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1856796

伴侣动物基因组学和诊断市场预测至2032年：按疾病类型、动物类型、应用、最终用户和地区分類的全球分析

Companion Animal Genomics & Diagnostics Market Forecasts to 2032 - Global Analysis By Disease Type, Animal Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球伴侣动物基因体学和诊断市场预计到 2025 年将达到 34 亿美元，到 2032 年将达到 62 亿美元，预测期内复合年增长率为 8.8%。

伴侣动物基因组学与诊断是兽医学的一个分支，专注于宠物的基因分析。此领域对犬、猫和其他伴侣动物进行DNA定序和解读，旨在识别品种特异性特征、遗传疾病易感性和独特的遗传特征。诊断应用利用这些遗传资讯进行遗传疾病筛检、确诊以及了解疾病的潜在分子机制。这为理解个体动物的遗传健康状况提供了科学基础。

据美国兽医协会称，基因序列测定和分子诊断技术的进步使得伴侣动物医疗保健领域能够更早发现疾病并采取个人化的治疗方法。

基因检测技术的进步

基因检测技术的进步正在革新伴侣动物基因组学和诊断市场，使遗传疾病、疾病易感性和品种鑑定能够精准识别。 DNA定序、生物标记分析和生物资讯平台的创新，正助力兽医和宠物饲主实施个人化医疗保健策略。这些进步提高了诊断准确性，支持预防性护理，并促进疾病的早期介入。高通量定序、行动报告和云端基础分析的整合，正在扩大检测的可及性和易用性，从而增强全球都市区兽医诊所的市场接受度。

高昂的诊断和定序成本

高昂的诊断和定序成本仍然是伴侣动物基因组学和诊断市场的主要限制因素，限制了注重成本的饲主采用这项技术。尤其是在新兴经济体，昂贵的检测程序、实验室费用和专有平台费用降低了技术的普及性。即使技术已经成熟，这些经济障碍也会阻碍技术的广泛应用。此外，针对特定症状或后续观察的重复检测也会增加累积成本。市场参与者必须在技术先进性和价格可负担之间取得平衡，以确保技术的持续成长，并促进不同饲主群体的广泛应用。

与兽医远端医疗平台建立合作关係

与兽医远端医疗平台建立合作关係，为伴侣动物基因组学和诊断市场带来了巨大的成长机会。将基因检测与虚拟兽医咨询相结合，能够实现远距离诊断、个人化治疗方案製定以及宠物疾病的早期发现。此类合作关係有助于将服务覆盖到服务不足的偏远地区，提升宠物饲主的便利性，并透过数位化平台加强互动。远端医疗伙伴关係还可以支援基于订阅的基因组监测，促进持续的健康管理，并为基因组学服务提供者带来稳定的收入来源。

基因资料库中的资料隐私风险

基因资料库中的资料隐私风险对伴侣动物基因组学和诊断市场构成重大威胁。敏感的基因组资讯可能容易受到未授权存取、网路攻击和滥用。资料外洩可能危及宠物饲主的隐私，削弱服务供应商的信任，并使您面临监管审查。安全储存、维护加密通讯协定以及遵守国家和国际资料保护法律至关重要。未能有效管理这些风险可能会影响市场采用率，阻碍伙伴关係，并损害在竞争激烈的基因组诊断领域的品牌声誉。

新冠疫情的影响：

新冠疫情的爆发加速了居家检测和远端医疗服务的需求，从而对伴侣动物基因组学和诊断市场产生了影响。宠物饲主越来越多地寻求远端解决方案进行预防保健和基因筛检，以减少就诊次数。实验室运作也随之调整，采用数位化报告、非接触式样本采集和宅配套件等方式。然而，供应链中断和样本处理延迟暂时影响了市场活动。整体而言，疫情凸显了远距离诊断服务和数位整合的重要性，巩固了伴侣动物基因体学的长期成长前景。

预测期内，感染疾病将是最大的细分市场。

感染疾病领域在伴侣动物基因组学和诊断市场中占据显着份额，预计在预测期内仍将保持最大的市场份额。细菌、病毒和感染疾病感染的治疗有助于早期发现、精准治疗并改善动物福利。由于传染病的高发生率和跨物种传播的可能性，兽医诊所和诊断实验室将感染疾病筛检列为优先事项。基因谱分析的整合能够强化预防策略、支持疫苗接种计画并确保精准干预，使该领域在未来几年成为整体市场收入的重要贡献者。

预计在预测期内，犬类市场将以最高的复合年增长率成长。

预计在预测期内，犬类市场将实现最高成长率，这主要得益于养犬人数的增加、宠物拟人化趋势的兴起以及人们对特定犬种健康状况日益增长的关注。犬饲主越来越多地投资于基因检测，用于疾病预防、追溯犬种血统和个人化营养。犬类基因体学的进步，加上远距远端医疗的日益普及，使得早期诊断介入更加便捷有效率。消费者的高度关注以及重复检测的潜力，使得犬类市场成为收入成长的关键驱动力，这反映出已开发市场和新兴市场均呈现强劲的成长趋势。

比最大的地区

预计亚太地区将在预测期内占据最大的市场份额。这主要归功于快速的都市化、宠物拥有率的上升以及人们对兽医保健意识的增强。中国、日本和印度等国家对先进的伴侣动物诊断技术表现出越来越浓厚的兴趣。远端医疗基础设施的扩展、可支配收入的增加以及数位素养的提高将进一步推动市场渗透。这些因素共同作用，使该地区成为全球市场收入的重要贡献者，并促进了都市区和半都市区兽医诊断行业的成长。

复合年增长率最高的地区：

在预测期内，北美预计将呈现最高的复合年增长率，这主要得益于其先进的兽医基础设施、较高的宠物拥有率以及基因组技术的广泛应用。美国和加拿大受益于完善的远端医疗平台、一体化的兽医网络以及技术成熟度。消费者在预防性护理和个人化宠物健康解决方案方面的高支出进一步推动了市场成长。这些因素，加上有利的法律规范和创新基因组学公司，使北美成为伴侣动物基因组学和诊断领域成长最快的区域市场。

免费客製化服务：

订阅本报告的用户可享有以下免费客製化服务之一：

  • 公司简介
    • 对其他市场参与者（最多 3 家公司）进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行市场估算、预测和复合年增长率分析（註：基于可行性检查）
  • 竞争基准化分析
    • 基于产品系列、地域覆盖和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究资讯来源
    • 初级研究资讯来源
    • 次级研究资讯来源
    • 先决条件

第三章 市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球伴侣动物基因体学和诊断市场（按疾病类型划分）

  • 感染疾病
  • 慢性病
  • 癌症/肿瘤检测
  • 遗传性疾病
  • 内分泌疾病
  • 其他疾病类型

6. 全球伴侣动物基因体学和诊断市场（按动物类型划分）

  • 狗
  • 猫
  • 马
  • 其他动物类型

7. 全球伴侣动物基因体学和诊断市场（按应用划分）

  • 临床病理
  • 毒理学
  • 细菌学
  • 寄生虫学
  • 妊娠测试
  • 其他用途

8. 全球伴侣动物基因体学和诊断市场（按最终用户划分）

  • 兽医医院和诊所
  • 诊断实验室
  • 研究所
  • 就地检验
  • 居家照护

9. 全球伴侣动物基因体学和诊断市场（按地区划分）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与併购
  • 新产品上市
  • 业务拓展
  • 其他关键策略

第十一章 企业概况

  • Mars Petcare
  • Embark Veterinary
  • Zoetis
  • IDEXX Laboratories
  • Basepaws
  • Neogen
  • Orivet Genetic Pet Care
  • Paw Print Genetics
  • VetGen
  • Animal Genetics Inc.
  • UC Davis Veterinary Genetics Laboratory
  • Genoscoper
  • EasyDNA
  • Heska Corporation
  • Genetic Veterinary Sciences
  • Virbac
  • Nestle Purina
  • Royal Canin
Product Code: SMRC31668

According to Stratistics MRC, the Global Companion Animal Genomics & Diagnostics Market is accounted for $3.4 billion in 2025 and is expected to reach $6.2 billion by 2032 growing at a CAGR of 8.8% during the forecast period. Companion Animal Genomics & Diagnostics is a field of veterinary science focused on the genetic analysis of pets. It involves sequencing and interpreting the DNA of dogs, cats, and other companion animals. This discipline identifies breed-specific composition, inherited disease predispositions, and unique genetic traits. Diagnostic applications use this genetic information to screen for hereditary conditions, confirm diagnoses, and understand the underlying molecular causes of diseases. It provides a scientific basis for understanding an individual animal's genetic health profile.

According to the American Veterinary Medical Association, advancements in genomic sequencing and molecular diagnostics are enabling earlier disease detection and personalized treatment approaches in companion animal healthcare.

Market Dynamics:

Driver:

Technological advancements in genetic testing

Technological advancements in genetic testing have revolutionized the Companion Animal Genomics & Diagnostics Market, enabling precise identification of hereditary conditions, disease predispositions, and breed verification. Innovations in DNA sequencing, biomarker analysis, and bioinformatics platforms allow veterinarians and pet owners to implement personalized healthcare strategies. These advancements enhance diagnostic accuracy, support preventive care, and facilitate early disease intervention. Integration of high-throughput sequencing, mobile reporting, and cloud-based analytics has expanded accessibility and usability, strengthening the market's adoption across urban and rural veterinary practices globally.

Restraint:

High diagnostic and sequencing costs

High diagnostic and sequencing costs remain a significant restraint in the Companion Animal Genomics & Diagnostics Market, limiting adoption among cost-sensitive pet owners. Expensive testing procedures, laboratory fees, and proprietary platform charges reduce accessibility, particularly in emerging economies. This financial barrier can impede widespread implementation despite technological readiness. Additionally, recurrent testing for certain conditions or follow-ups increases cumulative costs. Market players must balance technological sophistication with affordability to ensure sustained growth and broader adoption across diverse pet owner demographics.

Opportunity:

Partnerships with veterinary telehealth platforms

Partnerships with veterinary telehealth platforms present a substantial growth opportunity in the Companion Animal Genomics & Diagnostics Market. Integrating genetic testing with virtual veterinary consultations enables remote diagnostics, personalized treatment plans, and early disease detection for pets. Such collaborations expand reach to underserved or rural areas, increase convenience for pet owners, and enhance engagement through digital platforms. Telehealth partnerships can also support subscription-based genomic monitoring, promoting continuous health management and driving recurring revenue streams for genomics service providers.

Threat:

Data privacy risks in genetic databases

Data privacy risks in genetic databases pose a notable threat to the Companion Animal Genomics & Diagnostics Market. Sensitive genomic information can be vulnerable to unauthorized access, cyberattacks, or misuse. Breaches may compromise pet owner confidentiality, undermine trust in service providers, and attract regulatory scrutiny. Maintaining secure storage, encryption protocols, and compliance with local and international data protection laws is critical. Failure to manage these risks effectively can impact adoption rates, hinder partnerships, and damage brand reputation in the competitive genomic diagnostics sector.

Covid-19 Impact:

The Covid-19 pandemic influenced the Companion Animal Genomics & Diagnostics Market by accelerating demand for at-home testing and telehealth services. Pet owners increasingly sought remote solutions for preventive care and genetic screening to reduce clinic visits. Laboratory operations adapted with digital reporting, contactless sample collection, and home delivery kits. However, supply chain disruptions and delayed sample processing temporarily impacted market activity. Overall, the pandemic highlighted the importance of remote diagnostic services and digital integration, reinforcing long-term growth prospects in companion animal genomics.

The infectious diseases segment is expected to be the largest during the forecast period

The infectious diseases segment is expected to account for the largest market share during the forecast period, accounting for a substantial share of the Companion Animal Genomics & Diagnostics Market. Testing for bacterial, viral, and parasitic infections enables early detection, accurate treatment, and improved animal welfare. Veterinary clinics and diagnostic laboratories prioritize infectious disease screening due to high prevalence and potential cross-species transmission. Integration with genetic profiling enhances preventive strategies, supports vaccination planning, and ensures targeted interventions, solidifying this segment as the primary contributor to overall market revenue over the coming years.

The dogs segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the dogs segment is predicted to witness the highest growth rate, propelled by increasing dog ownership, pet humanization, and rising awareness of breed-specific health conditions. Dog owners increasingly invest in genetic testing for disease prevention, ancestry tracking, and personalized nutrition. Advances in canine genomics, coupled with growing telehealth adoption, facilitate convenient and early diagnostic interventions. High consumer engagement and repeat testing potential make the dogs segment a critical driver of revenue growth, reflecting strong adoption trends across both developed and emerging markets.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, attributed to rapid urbanization, rising pet adoption rates, and increasing veterinary healthcare awareness. Countries like China, Japan, and India exhibit growing interest in advanced companion animal diagnostics. Expanding telehealth infrastructure, rising disposable incomes, and increasing digital literacy further enhance market penetration. Collectively, these factors establish the region as a dominant contributor to global market revenue, supporting growth in both urban and semi-urban veterinary diagnostics segments.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR associated with advanced veterinary infrastructure, high pet ownership, and strong adoption of genomic technologies. The United States and Canada benefit from widespread telehealth platforms, veterinary network integration, and technological readiness. High consumer spending on preventive care and personalized pet health solutions further accelerates market growth. These conditions, combined with supportive regulatory frameworks and innovation-driven genomics companies, position North America as the fastest-growing regional market in companion animal genomics and diagnostics.

Key players in the market

Some of the key players in Companion Animal Genomics & Diagnostics Market include Mars Petcare, Embark Veterinary, Zoetis, IDEXX Laboratories, Basepaws, Neogen, Orivet Genetic Pet Care, Paw Print Genetics, VetGen, Animal Genetics Inc., UC Davis Veterinary Genetics Laboratory, Genoscoper, EasyDNA, Heska Corporation, Genetic Veterinary Sciences, Virbac, Nestle Purina, and Royal Canin.

Key Developments:

In August 2025, Embark Veterinary announced the new "Breed + Health Kit" with expanded screening for over 250 genetic health conditions and traits in dogs, providing breeders and owners with more comprehensive hereditary disease risk reports.

In July 2025, Zoetis launched the new Vetscan Imagyst(R) platform with integrated genomic analysis, designed to combine AI-powered digital cytology with genetic testing for streamlined in-clinic diagnostic workflows for companion animals.

In June 2025, IDEXX Laboratories announced the launch of its "Make in India" initiative for the IDEXX Genetic Intelligence Panel to support the expansion of affordable, localized premium diagnostic services for pets across the region.

Disease Types Covered:

  • Infectious Diseases
  • Chronic Diseases
  • Cancer & Tumor Detection
  • Genetic Disorders
  • Endocrine Disorders
  • Other Disease Types

Animal Types Covered:

  • Dogs
  • Cats
  • Horses
  • Other Animal Types

Applications Covered:

  • Clinical Pathology
  • Toxicology
  • Bacteriology
  • Parasitology
  • Pregnancy Testing
  • Other Applications

End Users Covered:

  • Veterinary Hospitals & Clinics
  • Diagnostic Laboratories
  • Research Institutions
  • Point-of-Care Testing
  • Home Care

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Companion Animal Genomics & Diagnostics Market, By Disease Type

  • 5.1 Introduction
  • 5.2 Infectious Diseases
  • 5.3 Chronic Diseases
  • 5.4 Cancer & Tumor Detection
  • 5.5 Genetic Disorders
  • 5.6 Endocrine Disorders
  • 5.7 Other Disease Types

6 Global Companion Animal Genomics & Diagnostics Market, By Animal Type

  • 6.1 Introduction
  • 6.2 Dogs
  • 6.3 Cats
  • 6.4 Horses
  • 6.5 Other Animal Types

7 Global Companion Animal Genomics & Diagnostics Market, By Application

  • 7.1 Introduction
  • 7.2 Clinical Pathology
  • 7.3 Toxicology
  • 7.4 Bacteriology
  • 7.5 Parasitology
  • 7.6 Pregnancy Testing
  • 7.7 Other Applications

8 Global Companion Animal Genomics & Diagnostics Market, By End User

  • 8.1 Introduction
  • 8.2 Veterinary Hospitals & Clinics
  • 8.3 Diagnostic Laboratories
  • 8.4 Research Institutions
  • 8.5 Point-of-Care Testing
  • 8.6 Home Care

9 Global Companion Animal Genomics & Diagnostics Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Mars Petcare
  • 11.2 Embark Veterinary
  • 11.3 Zoetis
  • 11.4 IDEXX Laboratories
  • 11.5 Basepaws
  • 11.6 Neogen
  • 11.7 Orivet Genetic Pet Care
  • 11.8 Paw Print Genetics
  • 11.9 VetGen
  • 11.10 Animal Genetics Inc.
  • 11.11 UC Davis Veterinary Genetics Laboratory
  • 11.12 Genoscoper
  • 11.13 EasyDNA
  • 11.14 Heska Corporation
  • 11.15 Genetic Veterinary Sciences
  • 11.16 Virbac
  • 11.17 Nestle Purina
  • 11.18 Royal Canin

List of Tables

  • Table 1 Global Companion Animal Genomics & Diagnostics Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Companion Animal Genomics & Diagnostics Market Outlook, By Disease Type (2024-2032) ($MN)
  • Table 3 Global Companion Animal Genomics & Diagnostics Market Outlook, By Infectious Diseases (2024-2032) ($MN)
  • Table 4 Global Companion Animal Genomics & Diagnostics Market Outlook, By Chronic Diseases (2024-2032) ($MN)
  • Table 5 Global Companion Animal Genomics & Diagnostics Market Outlook, By Cancer & Tumor Detection (2024-2032) ($MN)
  • Table 6 Global Companion Animal Genomics & Diagnostics Market Outlook, By Genetic Disorders (2024-2032) ($MN)
  • Table 7 Global Companion Animal Genomics & Diagnostics Market Outlook, By Endocrine Disorders (2024-2032) ($MN)
  • Table 8 Global Companion Animal Genomics & Diagnostics Market Outlook, By Other Disease Types (2024-2032) ($MN)
  • Table 9 Global Companion Animal Genomics & Diagnostics Market Outlook, By Animal Type (2024-2032) ($MN)
  • Table 10 Global Companion Animal Genomics & Diagnostics Market Outlook, By Dogs (2024-2032) ($MN)
  • Table 11 Global Companion Animal Genomics & Diagnostics Market Outlook, By Cats (2024-2032) ($MN)
  • Table 12 Global Companion Animal Genomics & Diagnostics Market Outlook, By Horses (2024-2032) ($MN)
  • Table 13 Global Companion Animal Genomics & Diagnostics Market Outlook, By Other Animal Types (2024-2032) ($MN)
  • Table 14 Global Companion Animal Genomics & Diagnostics Market Outlook, By Application (2024-2032) ($MN)
  • Table 15 Global Companion Animal Genomics & Diagnostics Market Outlook, By Clinical Pathology (2024-2032) ($MN)
  • Table 16 Global Companion Animal Genomics & Diagnostics Market Outlook, By Toxicology (2024-2032) ($MN)
  • Table 17 Global Companion Animal Genomics & Diagnostics Market Outlook, By Bacteriology (2024-2032) ($MN)
  • Table 18 Global Companion Animal Genomics & Diagnostics Market Outlook, By Parasitology (2024-2032) ($MN)
  • Table 19 Global Companion Animal Genomics & Diagnostics Market Outlook, By Pregnancy Testing (2024-2032) ($MN)
  • Table 20 Global Companion Animal Genomics & Diagnostics Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 21 Global Companion Animal Genomics & Diagnostics Market Outlook, By End User (2024-2032) ($MN)
  • Table 22 Global Companion Animal Genomics & Diagnostics Market Outlook, By Veterinary Hospitals & Clinics (2024-2032) ($MN)
  • Table 23 Global Companion Animal Genomics & Diagnostics Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
  • Table 24 Global Companion Animal Genomics & Diagnostics Market Outlook, By Research Institutions (2024-2032) ($MN)
  • Table 25 Global Companion Animal Genomics & Diagnostics Market Outlook, By Point-of-Care Testing (2024-2032) ($MN)
  • Table 26 Global Companion Animal Genomics & Diagnostics Market Outlook, By Home Care (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.